Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 26440 | 27.755 |
09:34 ET | 20064 | 27.755 |
09:36 ET | 2150 | 27.76 |
09:38 ET | 2300 | 27.76 |
09:39 ET | 8792 | 27.75 |
09:41 ET | 2033 | 27.805 |
09:43 ET | 9623 | 27.89 |
09:45 ET | 7803 | 27.885 |
09:48 ET | 2295 | 27.9 |
09:50 ET | 15000 | 27.91 |
09:52 ET | 3800 | 27.915 |
09:54 ET | 2400 | 27.88 |
09:56 ET | 6491 | 27.84 |
09:57 ET | 2000 | 27.83 |
09:59 ET | 629 | 27.865 |
10:01 ET | 4409 | 27.84 |
10:03 ET | 5386 | 27.82 |
10:06 ET | 8370 | 27.83 |
10:08 ET | 3429 | 27.85 |
10:10 ET | 1900 | 27.85 |
10:12 ET | 1503 | 27.825 |
10:14 ET | 1800 | 27.85 |
10:15 ET | 400 | 27.85 |
10:17 ET | 2073 | 27.84 |
10:19 ET | 2815 | 27.84 |
10:21 ET | 898 | 27.84 |
10:24 ET | 9314 | 27.81 |
10:26 ET | 29738 | 27.74 |
10:28 ET | 7000 | 27.75 |
10:30 ET | 10473 | 27.72 |
10:32 ET | 3682 | 27.7167 |
10:33 ET | 5685 | 27.74 |
10:35 ET | 2559 | 27.7597 |
10:37 ET | 868 | 27.7466 |
10:39 ET | 5387 | 27.68 |
10:42 ET | 2065 | 27.69 |
10:44 ET | 2070 | 27.6895 |
10:46 ET | 2000 | 27.69 |
10:48 ET | 500 | 27.69 |
10:50 ET | 1291 | 27.695 |
10:51 ET | 1045 | 27.715 |
10:53 ET | 1100 | 27.755 |
10:55 ET | 4522 | 27.74 |
10:57 ET | 6602 | 27.715 |
11:00 ET | 2554 | 27.715 |
11:02 ET | 3150 | 27.725 |
11:04 ET | 4580 | 27.705 |
11:06 ET | 3900 | 27.73 |
11:08 ET | 1299 | 27.735 |
11:09 ET | 720 | 27.76 |
11:11 ET | 3696 | 27.735 |
11:13 ET | 576 | 27.73 |
11:15 ET | 3363 | 27.745 |
11:18 ET | 2043 | 27.73 |
11:20 ET | 2100 | 27.715 |
11:22 ET | 1400 | 27.69 |
11:24 ET | 11544 | 27.635 |
11:26 ET | 3515 | 27.65 |
11:27 ET | 3500 | 27.655 |
11:29 ET | 1627 | 27.665 |
11:31 ET | 972 | 27.7 |
11:33 ET | 10511 | 27.68 |
11:36 ET | 3858 | 27.67 |
11:38 ET | 7130 | 27.685 |
11:40 ET | 3421 | 27.66 |
11:42 ET | 5000 | 27.665 |
11:44 ET | 7586 | 27.655 |
11:45 ET | 19998 | 27.67 |
11:47 ET | 7310 | 27.645 |
11:49 ET | 7416 | 27.63 |
11:51 ET | 2206 | 27.625 |
11:54 ET | 4152 | 27.63 |
11:56 ET | 6490 | 27.64 |
11:58 ET | 2120 | 27.6401 |
12:00 ET | 6787 | 27.645 |
12:02 ET | 4207 | 27.655 |
12:03 ET | 12058 | 27.7 |
12:05 ET | 6201 | 27.7 |
12:07 ET | 4611 | 27.72 |
12:09 ET | 806 | 27.735 |
12:12 ET | 1935 | 27.72 |
12:14 ET | 1801 | 27.72 |
12:16 ET | 850 | 27.735 |
12:18 ET | 3496 | 27.725 |
12:20 ET | 8572 | 27.73 |
12:21 ET | 4968 | 27.725 |
12:23 ET | 8273 | 27.73 |
12:25 ET | 1553 | 27.72 |
12:27 ET | 8269 | 27.72 |
12:30 ET | 2600 | 27.745 |
12:32 ET | 737 | 27.75 |
12:34 ET | 5453 | 27.77 |
12:36 ET | 2985 | 27.75 |
12:38 ET | 1335 | 27.78 |
12:39 ET | 1273 | 27.78 |
12:41 ET | 2284 | 27.76 |
12:43 ET | 736 | 27.765 |
12:45 ET | 2425 | 27.78 |
12:48 ET | 1800 | 27.795 |
12:50 ET | 620 | 27.7789 |
12:52 ET | 400 | 27.79 |
12:54 ET | 1825 | 27.77 |
12:56 ET | 4182 | 27.79 |
12:57 ET | 1799 | 27.785 |
12:59 ET | 1409 | 27.765 |
01:01 ET | 562 | 27.78 |
01:03 ET | 200 | 27.775 |
01:06 ET | 400 | 27.78 |
01:08 ET | 300 | 27.785 |
01:10 ET | 3752 | 27.79 |
01:12 ET | 1700 | 27.785 |
01:14 ET | 979 | 27.79 |
01:15 ET | 980 | 27.795 |
01:17 ET | 100 | 27.79 |
01:19 ET | 508 | 27.8 |
01:21 ET | 4238 | 27.795 |
01:24 ET | 7441 | 27.775 |
01:26 ET | 2263 | 27.765 |
01:28 ET | 1233 | 27.7721 |
01:30 ET | 800 | 27.78 |
01:32 ET | 1000 | 27.7761 |
01:33 ET | 2731 | 27.77 |
01:35 ET | 2600 | 27.78 |
01:37 ET | 2600 | 27.77 |
01:39 ET | 3585 | 27.75 |
01:42 ET | 11936 | 27.755 |
01:44 ET | 4316 | 27.745 |
01:46 ET | 3184 | 27.76 |
01:48 ET | 400 | 27.76 |
01:50 ET | 2500 | 27.75 |
01:51 ET | 2510 | 27.75 |
01:53 ET | 1100 | 27.755 |
01:55 ET | 2595 | 27.755 |
01:57 ET | 1408 | 27.75 |
02:00 ET | 1500 | 27.75 |
02:02 ET | 2515 | 27.74 |
02:04 ET | 6012 | 27.745 |
02:06 ET | 1366 | 27.73 |
02:08 ET | 900 | 27.735 |
02:09 ET | 600 | 27.735 |
02:11 ET | 1450 | 27.735 |
02:13 ET | 2445 | 27.735 |
02:15 ET | 2307 | 27.735 |
02:18 ET | 2550 | 27.715 |
02:20 ET | 2327 | 27.71 |
02:22 ET | 1799 | 27.715 |
02:24 ET | 4099 | 27.715 |
02:26 ET | 500 | 27.715 |
02:27 ET | 1674 | 27.715 |
02:29 ET | 4059 | 27.71 |
02:31 ET | 600 | 27.71 |
02:33 ET | 2499 | 27.7 |
02:36 ET | 3349 | 27.72 |
02:38 ET | 3436 | 27.71 |
02:40 ET | 1166 | 27.73 |
02:42 ET | 2736 | 27.73 |
02:44 ET | 2500 | 27.735 |
02:45 ET | 2265 | 27.725 |
02:47 ET | 1201 | 27.725 |
02:49 ET | 1601 | 27.735 |
02:51 ET | 2721 | 27.735 |
02:54 ET | 2423 | 27.745 |
02:56 ET | 22053 | 27.73 |
02:58 ET | 12521 | 27.74 |
03:00 ET | 15604 | 27.75 |
03:02 ET | 738 | 27.745 |
03:03 ET | 2947 | 27.745 |
03:05 ET | 1227 | 27.745 |
03:07 ET | 3364 | 27.7456 |
03:09 ET | 4868 | 27.75 |
03:12 ET | 1100 | 27.745 |
03:14 ET | 400 | 27.74 |
03:16 ET | 3719 | 27.745 |
03:18 ET | 3300 | 27.74 |
03:20 ET | 1659 | 27.74 |
03:21 ET | 10202 | 27.755 |
03:23 ET | 1868 | 27.745 |
03:25 ET | 4911 | 27.74 |
03:27 ET | 3045 | 27.74 |
03:30 ET | 2463 | 27.75 |
03:32 ET | 2554 | 27.75 |
03:34 ET | 3243 | 27.745 |
03:36 ET | 2830 | 27.755 |
03:38 ET | 2600 | 27.745 |
03:39 ET | 3348 | 27.745 |
03:41 ET | 1824 | 27.75 |
03:43 ET | 1125 | 27.755 |
03:45 ET | 14330 | 27.75 |
03:48 ET | 7370 | 27.745 |
03:50 ET | 5353 | 27.745 |
03:52 ET | 5616 | 27.745 |
03:54 ET | 8187 | 27.745 |
03:56 ET | 38660 | 27.745 |
03:57 ET | 60570 | 27.74 |
03:59 ET | 381312 | 27.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.5B | 18.4x | +1.83% |
Amneal Pharmaceuticals Inc | 2.7B | -13.9x | --- |
Endo Inc | 1.9B | 0.4x | --- |
Catalent Inc | 11.0B | -10.5x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 18.8x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.5B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 593.5M |
Dividend Yield | 3.03% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.4x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | 19.6x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.